Will Doctors Soon Prescribe Ecstasy?
Altered States
Challenges in Blinding and Regulation of Psychoactive Drug Trials
This chapter explores the intricacies of double-blind clinical trials for psychoactive drugs, particularly MDMA. It highlights the challenges of blinding in trials and the regulatory hurdles imposed by the FDA in managing MDMA-assisted therapy.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
